FOLEY HOAG LLP for ABBOTT LABORATORIES
A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.
Versions of this report
Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.
| Filing | Filed | Amount | Counted |
|---|---|---|---|
| 3rd Quarter - Report | Oct 20, 2010 | $30,000 | Replaced |
| 3rd Quarter - Report (this page) | Oct 22, 2010 | $60,000 | Replaced |
| 3rd Quarter - Amendment | Oct 22, 2010 | $60,000 | Yes |
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
S. 369, Preserve Access to Affordable Generics Act; H.R. 1706, Protecting Consumer Access to Generic Drugs Act; H.R. 573 and S. 501, Fair Prescription Drug Competition Act
| Lobbyist | Covered position, as disclosed |
|---|---|
| PAUL KIM | — |
Food Industry (safety, labeling, etc.) FOO
S.510 FDA Food Safety Modernization Act; H.R. 2749 Food Safety Enhancement Act of 2009; S. 3307 Healthy, Hunger-Free Kids Act of 2010; H.R. 5504 Improving Nutrition for America's Children Act
| Lobbyist | Covered position, as disclosed |
|---|---|
| PAUL KIM | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.